SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (155)12/3/1996 7:45:00 PM
From: Brad C. Dunlap   of 1762
 
Hi Benntt, in respect to Troster Singer the market maker who has been blasting the bids on the sell side with no regard in attempting to get as high a price as possible. Yesterday was a good example, the stock was moving higher on strong volume and even got a little over 26 bid. Troster could have sold bits and pieces at a time to ensure that their sell order did not lower the price to any great extent. Instead, in the course of less then 5 minutes they dumped approx. 50-70000 shares on the market in total reckless abandon. It appears that they almost wanted the stock to be lower. I have suspected short selling but this has never checked out with the monthly short interest that is reported the 3rd week of the month. Today they were at it again, but it was in much less volume and didin't have any significant effect on the stock. Anyway it sure was nice to see the biotechs due so well in today's mkt. Oh by the way the BCL-2 marker would be a great story for Joe Kernan on CNBC. I have a suspicion that we'll be hearing more about this over the weekend.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext